Registro:

Referencias:

• Aguirre-Ghiso, J.A., Frankel, P., Farias, E.F., Lu, Z., Jiang, H., Olsen, A., Feig, L.A., Foster, D.A., RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases (1999) Oncogene, 18, pp. 4718-4725
• Banerjee, A., Periyasamy, S., Wolf, I.M., Hinds, T.D., Jr., Yong, W., Shou, W., Sanchez, E.R., Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins (2008) Biochemistry, 47, pp. 10471-10480
• Baughman, G., Wiederrecht, G.J., Campbell, N.F., Martin, M.M., Bourgeois, S., FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition (1995) Mol. Cell Biol., 15, pp. 4395-4402
• Beliakoff, J., Whitesell, L., Hsp90: an emerging target for breast cancer therapy (2004) Anticancer Drugs, 15, pp. 651-662
• Borghi, A., Verstrepen, L., Beyaert, R., TRAF2 multitasking in TNF receptor-induced signaling to NF-kappaB, MAP kinases and cell death (2016) Biochem. Pharmacol.
• Colo, G.P., Rubio, M.F., Nojek, I.M., Werbajh, S.E., Echeverria, P.C., Alvarado, C.V., Nahmod, V.E., Costas, M.A., The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action (2008) Oncogene, 27, pp. 2430-2444
• Chambraud, B., Belabes, H., Fontaine-Lenoir, V., Fellous, A., Baulieu, E.E., The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation (2007) FASEB J., 21, pp. 2787-2797
• Chung, J., Khadka, P., Chung, I.K., Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation (2012) J. Cell Sci., 125, pp. 2684-2697
• Davies, T.H., Ning, Y.M., Sanchez, E.R., A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins (2002) J. Biol. Chem., 277, pp. 4597-4600
• DeZwaan, D.C., Freeman, B.C., HSP90 manages the ends (2010) Trends Biochem. Sci., 35, pp. 384-391
• Echeverria, P.C., Mazaira, G., Erlejman, A., Gomez-Sanchez, C., Piwien Pilipuk, G., Galigniana, M.D., Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta (2009) Mol. Cell Biol., 29, pp. 4788-4797
• Eisenstein, M., Telomeres: all's well that ends well (2011) Nature, 478, pp. S13-S15
• Ellsworth, K.A., Eckloff, B.W., Li, L., Moon, I., Fridley, B.L., Jenkins, G.D., Carlson, E., Wang, L., Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma (2013) PLoS One, 8, p. e70216
• Erlejman, A.G., De Leo, S.A., Mazaira, G.I., Molinari, A.M., Camisay, M.F., Fontana, V., Cox, M.B., Galigniana, M.D., NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity (2014) J. Biol. Chem., 289, pp. 26263-26276
• Erlejman, A.G., Lagadari, M., Galigniana, M.D., Hsp90-binding immunophilins as a potential new platform for drug treatment (2013) Future Med. Chem., 5, pp. 591-607
• Erlejman, A.G., Lagadari, M., Harris, D.C., Cox, M.B., Galigniana, M.D., Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52 (2014) Curr. Protein Pept. Sci., 15, pp. 205-215
• Feng, J., Funk, W.D., Wang, S.S., Weinrich, S.L., Avilion, A.A., Chiu, C.P., Adams, R.R., Yu, J., The RNA component of human telomerase (1995) Science, 269, pp. 1236-1241
• Forsythe, H.L., Jarvis, J.L., Turner, J.W., Elmore, L.W., Holt, S.E., Stable association of hsp90 and p23, but not hsp70, with active human telomerase (2001) J. Biol. Chem., 276, pp. 15571-15574
• Gaali, S., Kirschner, A., Cuboni, S., Hartmann, J., Kozany, C., Balsevich, G., Namendorf, C., Hausch, F., Selective inhibitors of the FK506-binding protein 51 by induced fit (2015) Nat. Chem. Biol., 11, pp. 33-37
• Galigniana, M.D., Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases (1998) Biochem. J., 333, pp. 555-563
• Galigniana, M.D., Steroid receptor coupling becomes nuclear (2012) Chem. Biol., 19, pp. 662-663
• Galigniana, M.D., Echeverria, P.C., Erlejman, A.G., Piwien-Pilipuk, G., Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore (2010) Nucleus, 1, pp. 299-308
• Galigniana, M.D., Erlejman, A.G., Monte, M., Gomez-Sanchez, C., Piwien-Pilipuk, G., The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events (2010) Mol. Cell Biol., 30, pp. 1285-1298
• Gallo, L.I., Ghini, A.A., Piwien Pilipuk, G., Galigniana, M.D., Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity (2007) Biochemistry, 46, pp. 14044-14057
• Gallo, L.I., Lagadari, M., Piwien-Pilipuk, G., Galigniana, M.D., The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress (2011) J. Biol. Chem., 286, pp. 30152-30160
• Gassen, N.C., Fries, G.R., Zannas, A.S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Rein, T., Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine (2015) Sci. Signal, 8, p. ra119
• Gassen, N.C., Hartmann, J., Schmidt, M.V., Rein, T., FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action (2015) Autophagy, 11, pp. 578-580
• Gassen, N.C., Hartmann, J., Zannas, A.S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Rein, T., FKBP51 inhibits GSK3beta and augments the effects of distinct psychotropic medications (2016) Mol. Psychiatry, 21, pp. 277-289
• Gassen, N.C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Kirmeier, T., Rein, T., Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans (2014) PLoS Med., 11, p. e1001755
• Guy, N.C., Garcia, Y.A., Sivils, J.C., Galigniana, M.D., Cox, M.B., Functions of the Hsp90-binding FKBP immunophilins (2015) Subcell Biochem., 78, pp. 35-68
• Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., Nourse, J., Crabtree, G.R., The mechanism of action of cyclosporin A and FK506 (1996) Clin. Immunol. Immunopathol., 80, pp. S40-S45
• Holt, S.E., Aisner, D.L., Baur, J., Tesmer, V.M., Dy, M., Ouellette, M., Trager, J.B., White, M.A., Functional requirement of p23 and Hsp90 in telomerase complexes (1999) Genes Dev., 13, pp. 817-826
• Holliday, R., Endless quest (1996) Bioessays, 18, pp. 3-5
• Hukezalie, K.R., Wong, J.M., Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme (2013) FEBS J., 280, pp. 3194-3204
• Jinwal, U.K., Koren, J., 3rd, Borysov, S.I., Schmid, A.B., Abisambra, J.F., Blair, L.J., Johnson, A.G., Dickey, C.A., The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules (2010) J. Neurosci., 30, pp. 591-599
• Kang, H.J., Kim, J.M., Bae, K.Y., Kim, S.W., Shin, I.S., Kim, H.R., Shin, M.G., Yoon, J.S., Longitudinal associations between BDNF promoter methylation and late-life depression (2015) Neurobiol. Aging, 36 (1764), pp. e1761-1767
• Kang, H.J., Kim, J.M., Kim, S.Y., Kim, S.W., Shin, I.S., Kim, H.R., Park, M.H., Yoon, J.S., A longitudinal study of BDNF promoter methylation and depression in breast Cancer (2015) Psychiatry Investig., 12, pp. 523-531
• Kim, J.M., Kang, H.J., Kim, S.Y., Kim, S.W., Shin, I.S., Kim, H.R., Park, M.H., Yoon, J.S., BDNF promoter methylation associated with suicidal ideation in patients with breast cancer (2015) Int. J. Psychiatry Med., 49, pp. 75-94
• Kim, Y.S., Kim, Y.J., Lee, J.M., Kim, E.K., Park, Y.J., Choe, S.K., Ko, H.J., Kang, C.Y., Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs (2012) J. Immunol., 188, pp. 4226-4234
• Komura, E., Chagraoui, H., Mansat de Mas, V., Blanchet, B., de Sepulveda, P., Larbret, F., Larghero, J., Giraudier, S., Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression (2003) Exp. Hematol., 31, pp. 622-630
• Lagadari, M., De Leo, S.A., Camisay, M.F., Galigniana, M.D., Erlejman, A.G., Regulation of NF-kappaB signalling cascade by immunophilins (2015) Curr. Mol. Pharmacol., 9, pp. 99-108
• Lee, J.H., Khadka, P., Baek, S.H., Chung, I.K., CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity (2010) J. Biol. Chem., 285, pp. 42033-42045
• Li, T.K., Baksh, S., Cristillo, A.D., Bierer, B.E., Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin (2002) J. Cell Biochem., 84, pp. 460-471
• Liu, T.M., Martina, M., Hutmacher, D.W., Hui, J.H., Lee, E.H., Lim, B., Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages (2007) Stem Cells, 25, pp. 750-760
• Maida, Y., Masutomi, K., Telomerase reverse transcriptase moonlights: therapeutic targets beyond telomerase (2015) Cancer Sci., 106, pp. 1486-1492
• Manda, G., Isvoranu, G., Comanescu, M.V., Manea, A., Debelec Butuner, B., Korkmaz, K.S., The redox biology network in cancer pathophysiology and therapeutics (2015) Redox Biol., 5, pp. 347-357
• Manders, E.M., Verbeek, F.J., Aten, J.A., Measurement of colocalization of objects in dual-color confocal images (1993) J. Microsc., 169, pp. 375-382
• Massard, C., Zermati, Y., Pauleau, A.L., Larochette, N., Metivier, D., Sabatier, L., Kroemer, G., Soria, J.C., hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway (2006) Oncogene, 25, pp. 4505-4514
• Mazaira, G.I., Camisay, M.F., De Leo, S., Erlejman, A.G., Galigniana, M.D., Biological relevance of Hsp90-binding immunophilins in cancer development and treatment (2016) Int. J. Cancer, 138, pp. 797-808
• Mazaira, G.I., Lagadari, M., Erlejman, A.G., Galigniana, M.D., The emerging role of TPR-domain immunophilins in the mechanism of action of steroid receptors (2014) Nucl. Receptor Res, 1, p. 17. , 101094
• McKinney, B.C., Lin, C.W., Oh, H., Tseng, G.C., Lewis, D.A., Sibille, E., Hypermethylation of BDNF and SST genes in the orbital frontal cortex of older individuals: a putative mechanism for declining gene expression with age (2015) Neuropsychopharmacology, 40, pp. 2604-2613
• Mendelsohn, A.R., Larrick, J.W., Epigenetic-mediated decline in synaptic plasticity during aging (2012) Rejuvenation Res., 15, pp. 98-101
• Menicanin, D., Bartold, P.M., Zannettino, A.C., Gronthos, S., Genomic profiling of mesenchymal stem cells (2009) Stem Cell Rev, 5, pp. 36-50
• Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Weinberg, R.A., hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization (1997) Cell, 90, pp. 785-795
• Mukaide, H., Adachi, Y., Taketani, S., Iwasaki, M., Koike-Kiriyama, N., Shigematsu, A., Shi, M., Ikehara, S., FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma (2008) Cancer Invest., 26, pp. 385-390
• Nair, S.C., Rimerman, R.A., Toran, E.J., Chen, S., Prapapanich, V., Butts, R.N., Smith, D.F., Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor (1997) Mol. Cell Biol., 17, pp. 594-603
• Ni, L., Yang, C.S., Gioeli, D., Frierson, H., Toft, D.O., Paschal, B.M., FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells (2010) Mol. Cell Biol., 30, pp. 1243-1253
• Pei, H., Li, L., Fridley, B.L., Jenkins, G.D., Kalari, K.R., Lingle, W., Petersen, G., Wang, L., FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt (2009) Cancer Cell, 16, pp. 259-266
• Periyasamy, S., Hinds, T., Jr., Shemshedini, L., Shou, W., Sanchez, E.R., FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A (2010) Oncogene, 29, pp. 1691-1701
• Pratt, W.B., Galigniana, M.D., Morishima, Y., Murphy, P.J., Role of molecular chaperones in steroid receptor action (2004) Essays Biochem., 40, pp. 41-58
• Quinta, H.R., Galigniana, M.D., The neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation (2012) Br. J. Pharmacol., 166, pp. 637-649
• Quintá, H.R., Maschi, D., Gomez-Sanchez, C., Piwien-Pilipuk, G., Galigniana, M.D., Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth (2010) J. Neurochem., 115, pp. 716-734
• Ratajczak, T., Cluning, C., Ward, B.K., Steroid receptor-associated immunophilins: a gateway to steroid signalling (2015) Clin. Biochem. Rev., 36, pp. 31-52
• Ratajczak, T., Ward, B.K., Minchin, R.F., Immunophilin chaperones in steroid receptor signalling (2003) Curr. Top Med. Chem., 3, pp. 1348-1357
• Romano, S., D'Angelillo, A., Pacelli, R., Staibano, S., De Luna, E., Bisogni, R., Eskelinen, E.L., Romano, M.F., Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells (2010) Cell Death Differ., 17, pp. 145-157
• Romano, S., D'Angelillo, A., Staibano, S., Ilardi, G., Romano, M.F., FK506-binding protein 51 is a possible novel tumoral marker (2010) Cell Death Dis., 1, p. e55
• Romano, S., Di Pace, A., Sorrentino, A., Bisogni, R., Sivero, L., Romano, M.F., FK506 binding proteins as targets in anticancer therapy (2010) Anticancer Agents Med. Chem., 10, pp. 651-656
• Romano, S., Mallardo, M., Romano, M.F., FKBP51 and the NF-kappaB regulatory pathway in cancer (2011) Curr. Opin. Pharmacol., 11, pp. 288-293
• Romano, S., Sorrentino, A., Di Pace, A.L., Nappo, G., Mercogliano, C., Romano, M.F., The emerging role of large immunophilin FK506 binding protein 51 in cancer (2011) Curr. Med. Chem., 18, pp. 5424-5429
• Romano, S., Staibano, S., Greco, A., Brunetti, A., Nappo, G., Ilardi, G., Martinelli, R., Romano, M.F., FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential (2013) Cell Death Dis., 4, p. e578
• Romano, S., Xiao, Y., Nakaya, M., D'Angelillo, A., Chang, M., Jin, J., Hausch, F., Sun, S.C., FKBP51 employs both scaffold and isomerase functions to promote NF-kappaB activation in melanoma (2015) Nucleic Acids Res., 43, pp. 6983-6993
• Salatino, M., Beguelin, W., Peters, M.G., Carnevale, R., Proietti, C.J., Galigniana, M.D., Vedoy, C.G., Elizalde, P.V., Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation (2006) Oncogene, 25, pp. 7723-7739
• Seimiya, H., Sawada, H., Muramatsu, Y., Shimizu, M., Ohko, K., Yamane, K., Tsuruo, T., Involvement of 14-3-3 proteins in nuclear localization of telomerase (2000) EMBO J., 19, pp. 2652-2661
• Sivils, J.C., Storer, C.L., Galigniana, M.D., Cox, M.B., Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52) (2011) Curr. Opin. Pharmacol., 11, pp. 314-319
• Stechschulte, L.A., Hinds, T.D., Jr., Ghanem, S.S., Shou, W., Najjar, S.M., Sanchez, E.R., FKBP51 reciprocally regulates GRalpha and PPARgamma activation via the Akt-p38 pathway (2014) Mol. Endocrinol., 28, pp. 1254-1264
• Stechschulte, L.A., Sanchez, E.R., FKBP51-a selective modulator of glucocorticoid and androgen sensitivity (2011) Curr. Opin. Pharmacol., 11, pp. 332-337
• Storer, C.L., Dickey, C.A., Galigniana, M.D., Rein, T., Cox, M.B., FKBP51 and FKBP52 in signaling and disease (2011) Trends Endocrinol. Metab., 22, pp. 481-490
• Thorne, J.L., Campbell, M.J., Nuclear receptors and the Warburg effect in cancer (2015) Int. J. Cancer, 137, pp. 1519-1527
• Toneatto, J., Guber, S., Charo, N.L., Susperreguy, S., Schwartz, J., Galigniana, M.D., Piwien-Pilipuk, G., Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation (2013) J. Cell Sci., 126, pp. 5357-5368
• Weiwad, M., Edlich, F., Kilka, S., Erdmann, F., Jarczowski, F., Dorn, M., Moutty, M.C., Fischer, G., Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins (2006) Biochemistry, 45, pp. 15776-15784
• Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F., Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells (2005) J. Biol. Chem., 280, pp. 4609-4616
• Xu, X., Su, B., Barndt, R.J., Chen, H., Xin, H., Yan, G., Chen, L., Shou, W., FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506 (2002) Transplantation, 73, pp. 1835-1838

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------